Evidence map›Paper›PMID 35390085›Full record

ArticlePloS one2022

The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.

Amelia Fiske, Franziska Schönweitz, Johanna Eichinger, Bettina Zimmermann, Nora Hangel, Anna Sierawska, Stuart McLennan, Alena Buyx

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amelia FiskeInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0001-7207-6897
Franziska SchönweitzInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0002-6195-4903
Johanna EichingerInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Bettina ZimmermannInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Nora HangelInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Anna SierawskaInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Stuart McLennanInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.
Alena BuyxInstitute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Public perceptions of COVID-19 vaccines are critical in reaching protective levels of herd immunity. Vaccine skepticism has always been relatively high in Germany, and surveys suggest that over the course of the pandemic, enthusiasm for the COVID-19 vaccine has dropped. Looking at the period just prior to the approval of the Pfizer/BioNTech and Moderna vaccines in Germany in the latter half of 2020, this paper aims to assess the reasons for and against COVID-19 vaccine uptake among residents of Germany, and to provide in-depth qualitative data to better understand and address concerns surrounding the safety and efficacy of a COVID-19 vaccine. Our findings indicate that there is widespread trust in German institutions and health experts to provide a safe vaccine for those who need it most. However, interviewees also point to the need for more information and the centrality of support from trusted medical authorities in making individual vaccination decisions. We also present the complexity of individual positions on vaccination, and suggest that vaccine hesitancy in relation to COVID-19 needs to be understood as a nuanced, and socially malleable, territory. This indicates that the goal of a vaccination campaign is not only achieving 'herd immunity,' but also a social endorsement of the collaborative effort that is required for a vaccine to be successful.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesGermanyHumansPandemicsSARS-CoV-2TrustVaccinationCOVID-19 VaccinesVaccines

Identifiers

PMID35390085
PMCPMC8989326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.